Login
$RIGL
$43.73 -$0.73 (1.64%) Live

$RIGL SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G
10 Nov 2026 SCHEDULE 13G
05 Nov 2026 8-K: Results of Operations and Financial Condition

SOUTH SAN FRANCISCO, Calif., November 5, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the thir...

05 Nov 2026 10-Q
03 Sep 2026 Form 4: Schorno Dean L, EVP & Chief Financial Officer

Gave up 928 shares to cover exercise price or tax ($44.1K) · Received 4,600 shares by exercise or conversion ($99.9K)

03 Sep 2026 Form 4: Santos David A, EVP, Chief Commercial Officer

Gave up 874 shares to cover exercise price or tax ($41.5K)

03 Sep 2026 Form 4: Rodriguez Raul R, Director

Gave up 2,424 shares to cover exercise price or tax ($115K)

03 Sep 2026 Form 4: Furey Raymond J., EVP, GC, CCO & Corp Sec

Gave up 877 shares to cover exercise price or tax ($41.7K)

14 Aug 2026 SCHEDULE 13G/A
13 Aug 2026 SCHEDULE 13G/A
04 Aug 2026 S-8
04 Aug 2026 8-K: Results of Operations and Financial Condition

SOUTH SAN FRANCISCO, Calif., August 4, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today reported financial results for the second...

04 Aug 2026 10-Q
10 Jul 2026 Form 4: Hannah Alison L., EVP, Chief Medical Officer

Received 24,400 shares as a grant or award

01 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

On July 1, 2026, Rigel Pharmaceuticals, Inc. (the "Company") announced that Alison L. Hannah, M.D. was appointed Executive Vice President and Chief Medical Officer of the Company. In connection with her appointment, Dr. Hannah resigned f...

24 Jun 2026 Form 4: Ali-Jackson Kamil, Director

Sold 2,500 shares ($87.5K)

22 Jun 2026 Form 4: Furey Raymond J., EVP, GC, CCO & Corp Sec

Granted 7,394 Employee Stock Option (right to buy)

22 Jun 2026 Form 4: Rojkjaer Lisa, EVP, Chief Medical Officer

Granted 16,769 Employee Stock Option (right to buy)

22 Jun 2026 Form 4: Rodriguez Raul R, Director

Granted 31,700 Employee Stock Option (right to buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support